Print
14 March 2018
GMP News
The Ministry of Industry and Trade of Russia amended its Administrative Rules for licensing the manufacturing of medicinal products.
According to the Ministry, the relevant order was elaborated and approved to improve the quality of provision, period and availability of results of this public service provided by the Ministry, create comfortable conditions for participants in relations arising during the provision of service for licensing the manufacturing of medicinal products for human use, and defining the period and sequence of activities (administrative procedures).
In particular, the Rules were supplemented by clause 16.1, which stipulates that the Ministry of Industry and Trade may not:
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.